TL;DR: S/X inventory returns. More chatter on Q3 Model 3 deliveries.
S/X/3 summary.
Not clear if they're on Glovis Splender or their might have been another small shipment, but many new S/X are now listed in inventory.
It appears most P/LR backlog will be cleared. Most, including those who ordered in June/July are getting delivery dates. Same for SR+ buyers who ordered in Q1 or earlier. Not yet clear when SR+ buyers who ordered in Q2/Q3 will get theirs. For 2020, each trim is ~1/3 of orders.
While updating my data, I noticed how much Japan has diminished as a market for Tesla. JPN used to account for almost 2% of WW sales during S intro. ~1% for X. But only ~0.5% for 3 at its peak. I expect it to go back up to ~0.5% in Q3, but not much more & less in Q4.
It's clearer on TTM bases. I seriously doubt Model 3 can push it up to 0.4~0.5% range.
It's not like subsidy has been lowered or anything. As many lemmings have told me, 3 should be more popular because of its somewhat smaller size & lower prices.
More likely, Tesla has already become stale. Cars are refreshed more frequently in JPN. In Japan, things are either popular forever (hi, Cyndi Lauper!) or out of fashion very quickly. Not much middle ground. Tesla seems to belong to the latter group.
JPN is the 3rd largest auto market in the world after China & US, accounting for 5~6% of WW auto sales. Prob. higher for luxury vehicles. It's also where range is not a huge issue & older shorter range Leaf sold reasonably well (Leaf still has >90% of BEV market share).
• • •
Missing some Tweet in this thread? You can try to
force a refresh
If anything S.Korea had more cases than usual, but fewer hospitalization. That makes sense, given that RSV is worse in <1. Delayed infection is a good thing.
What's ironic is that, if you follow the logic of "immunity debt" enthusiasts (charitably, tbf), you end up concluding that "freedom day" was even dumber than we already thought.
1/
For one, we know infection-induced immunity to many of these pathogens is fairly shot-lived. i.e. what happened yrs ago doesn't really matter.
2/
For another, not all pathogens are created equal. Some are more infectious/harder to control.
3/
Variant-specific PCR says suspected BA.5 was ~3/4 during 7/5~7/11. Almost all suspected BA.5 for the latest wk (7/12~7/18).
2/
Similar story for Kobe. L452R+ > 80% for 7/11~7/17 (1st table). Majority of sequences (2nd table) from 7/4~7/10 were BA.5. They show BA.2.12.1 under BA.2 in ( ), BA.2.75 in [ ].
Mini-thread on JPN Covid mortality data wrt "from" vs. "with".
(Meaning to do this since MHLW advisory board posted some useful data a month ago, so here it is.)
tl;dr: Covid is still the primary cause in majority of reported deaths & Omicron is bad.
1/
MHLW guideline essentially requires all deaths by Covid patients be reported, so the reported #s include some incidental cases. So what % is incidental?
2/
First, data from Kanagawa pref. (pop. 9.2m, 2nd largest) on the "primary" causes of death in Jan/Feb '22 (almost all Omicron).
Primary cause: 53.2%
Not primary cause: 32.1%
Undetermined: 14.7%
Note that "not primary cause" doesn't mean it wasn't a contributing factor.
2 lines overlapping for Alpha = ~2% CFR
Same for Delta & Omicron = ~0.3% CFR
Note the differences in Y-axes.
Most seniors got vaccinated after the peak of Alpha wave. Others during the Delta wave.
1/
Omicron wave is likely to peak next wk (likely already did in southern/western 1/3 of the country), so deaths likely to peak in late Feb. Looking like it'll be the deadliest wave so far.
2/
Roughly,
Spring '20: 1k
Summer/Autumn '20: 1k
Winter '20-'21: 7.5k
Spring '21 (Alpha): 7.5k
Summer '21 (Delta): 3k
Winter '22 (Omicron): ~800 so far.
Per case severity is clearly lower relative to pre-vaxx peaks, but high transmissibility makes that less relevant.
3/